Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuromuscular disorders in systemic malignancy

J P Stübgen1

  • 1Department of Neurology (A-569), Cornell University Medical College, New York, NY 10021, USA.

Current Opinion in Neurology
|October 23, 1997
PubMed
Summary

Paraneoplastic neuronopathies involve autoimmune attacks on neuronal proteins, with potential links to cancer. Research explores mechanisms, prevention strategies, and the impact of chemotherapy on peripheral nerves.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Facioscapulohumeral muscular dystrophy. Multimodal evoked potentials and electroretinogram.

Electromyography and clinical neurophysiology·2007
Same author

Facioscapulohumeral muscular dystrophy. A quantitative electromyographic study.

Electromyography and clinical neurophysiology·2007
Same author

Rigid spine syndrome (vacuolar variant). A quantitative electromyograhic study.

Electromyography and clinical neurophysiology·2007
Same author

Unilateral Adie pupil as sole ophthalmic sign of anti-Hu paraneoplastic syndrome.

Journal of neuro-ophthalmology : the official journal of the North American Neuro-Ophthalmology Society·2000
Same author

Predicting mortality in intensive care unit patients with stroke.

Critical care medicine·2000
Same author

Synovial fluid polymerase chain reaction as an aid to the diagnosis of central nervous system Whipple's disease.

Annals of neurology·1999

Area of Science:

  • Neurology
  • Immunology
  • Oncology

Background:

  • Paraneoplastic neuronopathies are autoimmune disorders targeting neuronal proteins, with debated humoral and cell-mediated mechanisms.
  • Neuromuscular manifestations in lymphoproliferative diseases challenge the distinction between neoplastic and paraneoplastic origins.
  • Peripheral nerve toxicity from chemotherapy agents impedes cancer treatment advancements.

Purpose of the Study:

  • To explore the autoimmune mechanisms underlying paraneoplastic neuronopathies.
  • To investigate the causes and prevention of specific neurological syndromes like lower motor neuron syndrome and brachial plexopathy.
  • To clarify the relationship between cancer and neurological disorders, including shared antigenic components.

Main Methods:

  • Review of postulated humoral and cell-mediated autoimmune mechanisms.

Related Experiment Videos

  • Analysis of radiation-induced lower motor neuron syndrome and brachial plexopathy.
  • Application of polymerase chain reaction to differentiate neoplastic and paraneoplastic neuromuscular conditions.
  • Investigation of shared antigenic components in paraneoplastic neuropathy and melanoma.

    • Main Results:

    • Autoimmune attack on neuronal proteins is the presumed cause of paraneoplastic neuronopathies.
    • Spinal column irradiation can cause proximal motor polyradiculopathy, leading to lower motor neuron syndrome.
    • Lower radiotherapy doses and axillary surgery may prevent brachial plexopathy in breast cancer patients.
    • Polymerase chain reaction challenges the clear distinction between neoplastic and paraneoplastic neuromuscular issues.
    • Shared antigens may link inflammatory neuropathy and malignant melanoma.
    • Chemotherapy toxicity to peripheral nerves limits treatment options for responsive tumors.

    Conclusions:

    • Paraneoplastic neuronopathies are complex autoimmune conditions with diverse clinical presentations.
    • Understanding these mechanisms is crucial for developing targeted therapies and preventive strategies.
    • Further research is needed to address chemotherapy-induced neurotoxicity and its impact on cancer patient outcomes.